---
title: "Wai Chun Bio-Technology Forecasts Lower Fiscal H1 Loss on Back of Increased Revenue"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276984686.md"
description: "Wai Chun Bio-Technology Forecasts Lower Fiscal H1 Loss on Back of Increased Revenue"
datetime: "2026-02-26T05:00:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276984686.md)
  - [en](https://longbridge.com/en/news/276984686.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276984686.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276984686.md) | [繁體中文](https://longbridge.com/zh-HK/news/276984686.md)


# Wai Chun Bio-Technology Forecasts Lower Fiscal H1 Loss on Back of Increased Revenue



### Related Stocks

- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/en/quote/159849.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/en/quote/159837.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [WAI CHUN BIOTEC (00660.HK)](https://longbridge.com/en/quote/00660.HK.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/en/quote/516500.CN.md)

## Related News & Research

- [Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines](https://longbridge.com/en/news/280923090.md)
- [UCB presents new Bimzelx data at AAD](https://longbridge.com/en/news/280813909.md)
- [Sunho Biologics Flags Audit Delays as Auditor Seeks More Documentation](https://longbridge.com/en/news/280992698.md)
- [22:54 ETHugel to enter ECM-based injectable market with aesthetic portfolio expansion](https://longbridge.com/en/news/281291767.md)
- [TransThera Sciences Widens Annual Loss Amid Continued R&D Spend](https://longbridge.com/en/news/281187419.md)